Velmanase Alfa

DRUG3 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

Alpha-Mannosidosis

Phase 3

Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis

WithdrawnNCT04031066

Chiesi Farmaceutici S.p.A.Alpha-Mannosidosis

Start: 2021-01-11End: 2021-12-29Updated: 2020-12-08

Unknown Phase

Expanded Access to Velmanase Alfa

Chiesi Farmaceutici S.p.A.Alpha-Mannosidosis

Updated: 2023-09-25

Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3

RecruitingNCT06184503

Chiesi Farmaceutici S.p.A.Alpha-Mannosidosis

Start: 2025-02-19End: 2029-09-30Target: 5Updated: 2025-05-16